ANP Technologies Gets FDA EUA for SARS-CoV-2 Rapid Antigen Test

Grantee News
September 28, 2021

ANP Technologies announced on Monday that its SARS-CoV-2 rapid antigen test has received Emergency Use Authorization from the US Food and Drug Administration. Read more 360Dx

Explore More

There is so much more to explore at NIBIB.

Health Topics

Research Topics

Divisions